Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Cian Healthcare Ltd.

NSE: 12541583 | BSE:542678

₹24.10 -0.37 (-1.51%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

24.00

Today’s High

24.90

52W low

16.00

52W High

27.80

Open Price

24.40

Prev. Close

21.8200

Volume

40000.00

Value

964000.00

Fundamentals

Market Cap

60.20

Price to Earnings

0.00

Price to Book Value

1.00

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

11.76

Return on Equity %

0.44

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

5Day EMA

24.1

10Day EMA

24.1

12Day EMA

24.1

20Day EMA

23.9

26Day EMA

23.8

50Day EMA

23.2

100Day EMA

22.6

200Day EMA

22.6

5Day SMA

23.9

10Day SMA

24.1

20Day SMA

24.2

30Day SMA

23.9

50Day SMA

22.9

100Day SMA

22.5

150Day SMA

21.4

200Day SMA

21.7

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

80

Week

75.9

Month

81.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

24.35

PIVOT

First Resistance

24.69

Second Resistance

25.29

Third Resistance

25.63

First Support

23.75

Second Support

23.41

Third Support

22.81

Relative Strength Index

52.34

Money Flow Index

51.91

MACD

0.29

MACD Signal

0.4

Average True Range

1.47

Average Directional Index

15.98

Rate of Change (21)

12.72

Rate of Change (125)

39.79

Commodity Channel Index

26.5

Williams %R

-56.8

BETA

1 Month

0.38

3 Month

0.37

1 Year

0.16

3 Year

-0.43

PRICE CHANGE ANALYSIS

↓ -1.63%

1 Week

Low

High

22.5

25

↑ 12.72%

1 Month

Low

High

21.38

26.5

↑ 15.31%

3 Months

Low

High

19.88

26.5

↑ 42.27%

6 Months

Low

High

16.05

26.5

↓ -8.57%

1 Year

Low

High

16.05

27.75

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 59.81 68.10 64.57 72.59 57.84
Operating Expenses Annual Cr 51.39 59.10 59.17 63.06 49.43
Operating Profit Annual 7.36 8.46 4.93 9.32 7.62
Operating Profit Margin Annual % 12.30 12.42 7.63 12.85 13.17
Total Expenses Annual Cr 59.80 66.93 66.88 71.72 57.69
EBIDT Annual Cr 8.42 9.00 5.40 9.53 8.41
EBIDT Annual margin % 14.08 13.21 8.36 13.12 14.53
Depreciation 3.68 3.64 2.57 2.45 2.45
PAT Before ExtraOrdinary Items Annual Cr 0.39 1.08 -2.21 0.53 -0.00
Net Profit Annual 0.39 1.08 -2.28 0.33 -0.07
Basic EPS Annual 0.16 0.43 -0.96 0.14 -0.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 61.81 61.42 60.35 59.87 59.55
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 24.92 21.22 22.57 21.71 27.44
Total Current Liabilities Annual Cr 56.16 57.99 56.87 53.05 47.70
Total Capital Plus Liabilities Annual Cr 142.89 140.63 139.78 134.63 134.69
Fixed Assets Annual 40.58 43.30 45.82 44.44 45.58
Total Non Current Assets Annual 78.13 72.39 70.99 76.96 83.14
Total Current Assets Annual 64.76 68.24 68.79 57.67 51.55
Total Assets Annual 142.89 140.63 139.78 134.63 134.69
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 6.94 2.15 5.51 5.46 -9.24
Cash from Investing Activity Annual -0.93 -1.08 -3.85 -1.20 -25.16
Cash from Financing Annual Activity -6.41 -1.17 -2.65 -5.07 35.09
Net Cash Flow Annual - -0.10 -0.99 -0.81 0.69
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 24.73 24.57 24.14 25.62 25.48
ROE Annual % 0.63 1.75 -3.77 0.54 -0.12
ROCE Annual % 5.46 6.47 3.41 8.67 6.84
Total Debt to Total Equity Annual 0.66 0.70 0.71 0.83 0.86
EBDIT Annual Margin % 14.33 13.31 8.42 13.16 14.73
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 62.14 69.21 78.41 74.01 57.95
Operating Expenses Annual Cr 50.83 56.21 73.62 61.94 49.84
Operating Profit Annual 10.86 12.38 4.25 11.79 7.25
Operating Profit Margin Annual % 17.48 17.89 5.42 15.93 12.51
Total Expenses Annual Cr 62.09 67.33 84.34 73.11 61.41
EBIDT Annual Cr 11.30 13.00 4.79 12.07 8.11
EBIDT Annual margin % 18.19 18.78 6.10 16.31 14.00
Depreciation 5.47 5.43 4.27 3.45 4.45
PAT Before ExtraOrdinary Items Annual Cr 0.25 2.03 -5.46 0.26 -3.72
Net Profit Annual 0.25 2.03 -5.53 0.05 -3.79
Basic EPS Annual 0.10 0.81 -2.32 0.02 -1.62
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 57.74 57.49 55.46 58.24 58.19
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 37.32 37.73 41.03 41.22 49.87
Total Current Liabilities Annual Cr 34.84 65.27 69.45 57.79 48.48
Total Capital Plus Liabilities Annual Cr 72.16 160.48 165.94 157.25 156.54
Fixed Assets Annual 53.98 58.47 62.58 62.47 64.45
Total Non Current Assets Annual 89.43 86.24 86.98 93.89 102.30
Total Current Assets Annual 71.74 74.24 78.96 63.37 54.24
Total Assets Annual 161.18 160.48 165.94 157.25 156.54
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 11.76 4.84 8.58 5.93 -7.31
Cash from Investing Activity Annual -1.46 2.55 1.40 2.71 -27.44
Cash from Financing Annual Activity -10.44 -7.41 -10.96 -9.78 35.78
Net Cash Flow Annual - -0.01 -0.98 -1.13 1.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 23.10 23.00 22.19 24.92 24.89
ROE Annual % 0.44 3.53 -9.97 0.09 -6.51
ROCE Annual % 4.62 7.94 0.53 8.66 3.39
Total Debt to Total Equity Annual 0.96 1.06 1.14 1.22 1.26
EBDIT Annual Margin % 18.32 18.94 6.14 16.37 14.20
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
PANKAJ SHRINIWAS ZANWAR 13.76 74525946 12.21 0
SURAJ SHRINIWAS ZANWAR 10.09 74525947 99.77 0
SHAKUNTALA SHRINIWAS ZANWAR 2.04 74525948 0 0
KAVITA SURAJ ZANWAR 1.21 74525949 99.34 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
PRAKASHCHANDRA RATHI 15.42 74525960
RAVI ASHOK KOTHARI 2.52 74525961
GIRIJA AMIT SHARMA 1.82 74525962
KOUSHAL GOVINDPRASAD SHARMA 1.6 74525963
KAUSHAL SUNIL TAMBE 1.5 74525964
ARCHANA MANDHANI 1.16 74525965
SHWETA SACHIN BHANSALI 1.05 74525966
HUF 2.87 74525953
SAHI TRADING PRIVATE LIMITED 4.02 74525956
DAYAL TOURS AND TRAVELS INDIA PRIVATE LIMITED 2 74525957
SONALI DILIP SANKLECHA 4 74525968
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Jul 09, 2024 Preferential issue of shares -
Jun 14, 2024 Others Inter-alia, (1) To Discuss and reconsider the Investment Planning and Fund-raising Proposal etc.
May 30, 2024 Audited Results -
Nov 14, 2023 Half Yearly Results -
May 30, 2023 Audited Results -
Nov 14, 2022 Half Yearly Results -
May 30, 2022 Audited Results -
Dec 22, 2021 Preferential Issue of shares (Revised)
Nov 16, 2021 Half Yearly Results (Revised)
Oct 29, 2021 Preferential Issue of shares -
Oct 16, 2021 Preferential issue of shares -
Sep 18, 2021 Others Inter alia, 1. To consider and approve Proposal of Alteration of Capital Clause of Memorandum of Association of Company.
Jun 30, 2021 Audited Results -
Nov 13, 2020 Half Yearly Results -
Aug 31, 2020 Audited Results -
Nov 12, 2019 Half Yearly Results -
Sep 30, 2019 Audited Results Inter alia, to consider and approve 1.To consider and approve Audited Financial Statements of the Company for the year ended 31st March 2019.
Ex-Date Bonus Ratio Record Date
Bigul
03 Jul 2024

Cian Healthcare Ltd - 542678 - Board Meeting Intimation for Increase In Authorized Capital Of Company And To Considered And Approve The Proposal Of Issue Of Equity Shares On Preferential Basic.

 Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2024 ,inter alia, to consider and approve Increase in Authorized Capital of company and to considered and approve the proposal of issue of equity shares on preferential basic.
Bigul
03 Jul 2024

Cian Healthcare Ltd - 542678 - Intimation Of Receipt Of In-Principle Approval For Listing And Trading Equity Shares Of Company On BSE Main Board Platform.

 Intimation of receipt of In-Principle approval for Listing and Trading equity shares of company on BSE Main Board Platform.
Bigul
01 Jul 2024

Cian Healthcare Ltd - 542678 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 01, 2024 for Pankaj Shriniwas Zanwar & Others
Bigul
24 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Submission of Order of NCLT for Withdrawal of Case Titled Shreeji Pharmachem Vs Cian Healthcare Limited Having Case No. IA 3161 of 2024 in C.P. (IB)/149(MB)2022.
Bigul
21 Jun 2024

Cian Healthcare Ltd - 542678 - Intimation Of Withdrawal Of Matter Admitted By National Company Law Tribunal (NCLT), Mumbai Bench.

 Intimation of Withdrawal of Matter admitted by National Company Law Tribunal (NCLT), Mumbai bench.
Bigul
21 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Intimation of Withdrawal of matter admitted by National Company Law Tribunal, Mumbai bench.
Bigul
15 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Intimation of Settlement Agreement entered between Shreeji Pharmachem (OC) and Cian Healthcare Limited (OD) for withdrawal of Matter.
Bigul
12 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)

 Application bearing C.P. (IB) No. 149/MB/2022 for initiating CIRP in respect of Cian Healthcare Ltd is admitted.
Bigul
12 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)

 Update on CP (IB) No. 149/MB/2022_Appointment of Interim Resolution Professional
Bigul
12 Jun 2024

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal

 Application bearing C.P (B) No. 149/MB/2022 Under Section 9 of IBC for initiation of CIRP is admitted
See all News

FAQs

The latest market price of Cian Healthcare Ltd. on NSE was Rs. 24.10 as of today.

The opening share price of Cian Healthcare Ltd. was Rs. 24.40 as of today.

The 52-week high share price of Cian Healthcare Ltd. was Rs. 27.80.

The 52 week low share price of Cian Healthcare Ltd. was Rs. 16.00.

Please find Corporate actions section for more details.

The PE ratio of Cian Healthcare Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Cian Healthcare Ltd..

Close

Let's Open Free Demat Account